| Prev Close | 69.50 |
| Day Low/High | 69.09 / 70.28 |
| 52 Wk Low/High | 57.68 / 94.24 |
| Avg Volume | 1.15M |
| Exchange | NASDAQ |
| Shares Outstanding | 86.56M |
| Market Cap | 6.02B |
| EPS | -0.80 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Fitbit (NYSE:FIT), the leading global wearables brand, and DexCom, Inc.
DexCom, Inc. (Nasdaq: DXCM), announced today the publication of a new study that shows people with Type 2 diabetes on a multiple daily injection (MDI) insulin therapy benefit from the use of continuous glucose monitoring...
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BETR, CG, DXCM, ITG, JLL, KEM, NUS, STRL, SUM, SWIR Downgrades: DVA, GHC, ISCA, QRVO, RDC, SCMP Initiations: ASPU Read on to get TheStreet Quant Ratings' detailed report:
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Matthew Dolan, VP Corporate Development, will present an update on the...
DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended June 30, 2017.
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Steven Pacelli, Executive Vice President, Strategy and Corporate...
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2017 financial results after market close on Tuesday, August 1, 2017.
After a slump early last year, the smartwatch's sales have been rebounding.
DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, is presenting important clinical data for patients with type 1 and type 2 diabetes, at the American Diabetes...
DexCom, Inc. (NASDAQ: DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, announced today that it incorporated Ambulatory Glucose Profile (AGP) into its Dexcom CLARITY software.
DexCom's app tracks glucose levels for people with diabetes.
DexCom, Inc. (Nasdaq: DXCM) the leader in continuous glucose monitoring (CGM) for people with diabetes, is pleased to announce the Food and Drug Administration (FDA) approval of the Dexcom G5 mobile app for Android...
After a slump early last year, the smartwatch's sales have been rebounding. New features unveiled at Apple's WWDC conference could aid its momentum later this year.
Apple will release a new Bluetooth API for the Apple Watch.
First serious down day in ages? Jim Cramer says it's as normal as rain; and he has an umbrella for you.
DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conference: Kevin Sayer, President & Chief Executive Officer, will present on...
DexCom, Inc. (Nasdaq: DXCM) ("DexCom") announced today the pricing of its offering of $350 million aggregate principal amount of 0.
DexCom, Inc. (Nasdaq: DXCM) ("DexCom") announced today that it intends to offer, subject to market conditions and other factors, $300 million aggregate principal amount of Convertible Senior Notes due 2022 (the "notes") in...
DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended March 31, 2017.
A few important takeaways from our daily Facebook show with Jim Cramer.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer said reports of Apple developing a diabetes testing product is not a reason to own the stock.
Old-line momentum favorites fare well.
Old-line momentum favorites fare well.
DexCom, Inc. (NASDAQ:DXCM), the leader in continuous glucose monitoring (CGM) for people with diabetes, is pleased to announce that the U.
DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2017 financial results after market close on Tuesday, May 2, 2017.
Jim Cramer says economic fundamentals remain strong and this market's rallying with relief at Fed's anticipated rate hike.
DexCom, Inc. (Nasdaq: DXCM) today announced that Richard Collins has been appointed to the company's Board of Directors, effective March 9, 2017.
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2016.
